Overview

An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization

Status:
Recruiting

Trial end date:
2022-03-28

Target enrollment:

Participant gender:

Summary

The purpose of this Clinical trial is to explore the therapeutic benefits of Ivermectin and Doxycycline in different combinations in high risk patients diagnosed with COVID-19.

Phase:

Phase 4

Details

Lead Sponsor:

Max Health, Subsero Health

Treatments:

Doxycycline
Ivermectin